Full Text
Gefitinib, Erlotinib and Chemotherapy as Second-Line Treatment for Patient with Advanced Non-Small Lung Cancer (NSCLC)

Abstract

Authors

M Yang EC Tan Y Chen

Back to Volume 19, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×